Elite Pharmaceuticals, Inc. (QB) Stock Price - ELTP

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Elite Pharmaceuticals, Inc. (QB) ELTP Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.0074 14.07% 0.06 0.065 0.05 0.0526 0.0526 16:00:00
Bid Price Ask Price Spread Spread % News
0.058 0.062 0.004 6.45% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
179 4,340,253 $ 0.058530 $ 254,033 561,486 0.05 - 0.1289
Last Trade Time Type Quantity Stock Price Currency
15:58:06 10,000 $ 0.06 USD

Elite Pharmaceuticals, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 49.7M 828.39M $ -3.67M - -13.53 734.12M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Elite Pharmaceuticals, Inc. (QB) News

Latest ELTP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ELTP Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.068250.0850.050.058859k4M1M-0.00825-12.09%
1 Month0.080.0890.050.067859k4M487k-0.02-25.00%
3 Months0.09250.1040.050.083459k4M475k-0.0325-35.14%
6 Months0.08890.110.050.086059k4M524k-0.0289-32.51%
1 Year0.09090.12890.050.092159k7M661k-0.0309-33.99%
3 Years0.348970.3950.050.143720k20M939k-0.28897-82.81%
5 Years0.38050.46550.050.217120k20M1M-0.3205-84.23%

Elite Pharmaceuticals, Inc. (QB) Description

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry. Elite owns generic products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories, and Glenmark Pharmaceuticals, Inc., USA. Elite currently has eight commercial products being sold, six products filed with the FDA, additional approved products pending manufacturing site transfer and the NDA filing for Sequest Elite's pipeline products include abuse-deterrent opioids which utilize the Company's patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.